Effects of Docosahexaenoic Acid (DHA) on oxidative stress parameters, inflammation, and resolvin D1 expression in a mouse model of neuroinflammation

Background: Neuroinflammation is a defense mechanism of the central nervous system against injury, involving the activation of glial cells and the release of pro-inflammatory mediators. When prolonged or excessive, this response can contribute to neurodegenerative diseases such as Alzheimer's disease, multiple sclerosis, and anxio-depressive disorders. Docosahexaenoic acid (DHA), the main omega-3 fatty acid in the brain, is the precursor of specialized pro-resolving mediators (SPMs), including resolvin D1 (RvD1). However, its capacity to modulate RvD1 production in the context of neuroinflammation remains poorly documented.Aim and Objectives: To evaluate the effect of DHA supplementation on oxidative stress and inflammatory parameters, as well as on RvD1 expression, in a murine model of neuroinflammation.Materials and Methods: Thirty male BALB/c mice (11.7 – 30.2 g) were divided into three groups of 10 mice each: control (H2O); LPS (500 µg/kg, i.p., 7 days); and LPS+DHA (55 mg/kg, orally). Neuroinflammation was induced by intraperitoneal administration of lipopolysaccharide (LPS, 500 µg/kg, 7 days). Animals were then treated with DHA (55 mg/kg, orally) for 7 days. Twenty-four hours after the last treatment, blood samples were collected, after which the animals were sacrificed and the brains removed. Oxidative stress parameters (NO, nNOS, MDA, SOD, GPx) and inflammatory parameters (TNF-α, IL-1β, IL-6, IL-10), as well as RvD1 levels, were measured in serum and brain homogenates by ELISA.Results: DHA restored serum GPx activity (45.08 µmol/mL) and reduced serum SOD activity, NO levels, and nNOS expression, as well as brain MDA levels (14.8 µmol/mg). It increased brain RvD1 concentrations (from 786 to 2880 pg/mg, p = 0.04) and serum RvD1 concentrations (from 1046 pg/mL to 3710 pg/mL, p ≤ 0.0001).Conclusion: Our results suggest that DHA supplementation significantly attenuates brain oxidative stress and stimulates RvD1 production.

Authors

Publication Details

Journal
IP Indian Journal of Neurosciences
Published
2026-10-28
DOI
https://doi.org/10.18231/j.ijn.19009.1790663408
Primary Topic
Fatty Acid Research and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Docosahexaenoic Acid (DHA) on oxidative stress parameters, inflammation, and resolvin D1 expression in a mouse model of neuroinflammation

Choupette Ravelle Dobhat-Doukakini, Donatien Moukassa, Landry Martial Miguel, Destin Maurelien Mbemba-Bahamboula et al.
IP Indian Journal of Neurosciences
Fatty Acid Research and Health
article

Effects of Docosahexaenoic Acid (DHA) on oxidative stress parameters, inflammation, and resolvin D1 expression in a mouse model of neuroinflammation

Choupette Ravelle Dobhat-Doukakini, Donatien Moukassa, Landry Martial Miguel, Destin Maurelien Mbemba-Bahamboula, Ange Antoine .
article en

Abstract

Background: Neuroinflammation is a defense mechanism of the central nervous system against injury, involving the activation of glial cells and the release of pro-inflammatory mediators. When prolonged or excessive, this response can contribute to neurodegenerative diseases such as Alzheimer's disease, multiple sclerosis, and anxio-depressive disorders. Docosahexaenoic acid (DHA), the main omega-3 fatty acid in the brain, is the precursor of specialized pro-resolving mediators (SPMs), including resolvin D1 (RvD1). However, its capacity to modulate RvD1 production in the context of neuroinflammation remains poorly documented.Aim and Objectives: To evaluate the effect of DHA supplementation on oxidative stress and inflammatory parameters, as well as on RvD1 expression, in a murine model of neuroinflammation.Materials and Methods: Thirty male BALB/c mice (11.7 – 30.2 g) were divided into three groups of 10 mice each: control (H2O); LPS (500 µg/kg, i.p., 7 days); and LPS+DHA (55 mg/kg, orally). Neuroinflammation was induced by intraperitoneal administration of lipopolysaccharide (LPS, 500 µg/kg, 7 days). Animals were then treated with DHA (55 mg/kg, orally) for 7 days. Twenty-four hours after the last treatment, blood samples were collected, after which the animals were sacrificed and the brains removed. Oxidative stress parameters (NO, nNOS, MDA, SOD, GPx) and inflammatory parameters (TNF-α, IL-1β, IL-6, IL-10), as well as RvD1 levels, were measured in serum and brain homogenates by ELISA.Results: DHA restored serum GPx activity (45.08 µmol/mL) and reduced serum SOD activity, NO levels, and nNOS expression, as well as brain MDA levels (14.8 µmol/mg). It increased brain RvD1 concentrations (from 786 to 2880 pg/mg, p = 0.04) and serum RvD1 concentrations (from 1046 pg/mL to 3710 pg/mL, p ≤ 0.0001).Conclusion: Our results suggest that DHA supplementation significantly attenuates brain oxidative stress and stimulates RvD1 production.

IP Indian Journal of NeurosciencesVol. 12(3)
Good health and well-being
Openalex Percentile: Top 13%
Fatty Acid Research and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Effects of Docosahexaenoic Acid (DHA) on oxidative stress parameters, inflammation, and resolvin D1 expression in a mouse model of neuroinflammation — Choupette Ravelle Dobhat-Doukakini, Donatien Moukassa, et al. · IP Indian Journal of Neurosciences (2026) | TGRS Research Map | TGRS